|Multinational, domestic and foreign biopharmaceutical companies, specifically teams supporting a product launch into the U.S. market:
• Brand teams
• Payer access teams
• Forecasting teams
• Products in phases II/III, launch or 1 year post-launch
SkyLaunch leadership collaborates with your team to conduct in-depth data analytics and calibrate a “bottom-up” payer access and sales forecasting launch strategy tool for almost any therapeutic area in the U.S. market.